Brief: Nevro Announces Three Important Clinical Data Publications For Treating Painful Diabetic Neuropathy With 10 Khz Therapy

Nevro

29/11/2021 16:16

Nov 29 (Reuters) - Nevro Corp  NVRO.N :
    * NEVRO ANNOUNCES THREE IMPORTANT CLINICAL DATA PUBLICATIONS
FOR
TREATING PAINFUL DIABETIC NEUROPATHY WITH 10 KHZ THERAPY
    * NEVRO CORP - SENZA-PDN 12-MONTH DATA RANDOMIZED CONTROLLED
TRIAL
SHOW HFX FOR PDN SIGNIFICANTLY, DURABLY REDUCES PAINFUL DIABETIC
NEUROPATHY SYMPTOMS
    * NEVRO CORP - IN SENZA-PDN 12-MONTH TRIAL, SAFETY WAS
CONSISTENT
WITH PUBLISHED REPORTS OF ADVERSE EVENT RATES IN TRADITIONAL SCS
TRIALS

Source text for Eikon:  urn:newsml:reuters.com:*:nPn6CFprsa
Further company coverage:  NVRO.N 

 ((Reuters.Briefs@thomsonreuters.com;;))